Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Granuloma Annulare Secondary to Vemurafenib Therapy for Lung Adenocarcinoma.

Jenkinson HA, Siroy AE, Choksi A.

J Drugs Dermatol. 2017 Oct 1;16(10):1050-1052.

PMID:
29036262
2.

Clinicopathological features and clinical outcomes associated with TP53 and BRAFNon-V600 mutations in cutaneous melanoma patients.

Kim DW, Haydu LE, Joon AY, Bassett RL Jr, Siroy AE, Tetzlaff MT, Routbort MJ, Amaria RN, Wargo JA, McQuade JL, Kemnade J, Hwu P, Woodman SE, Roszik J, Kim KB, Gershenwald JE, Lazar AJ, Davies MA.

Cancer. 2017 Apr 15;123(8):1372-1381. doi: 10.1002/cncr.30463. Epub 2016 Dec 2.

3.

Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.

Roszik J, Haydu LE, Hess KR, Oba J, Joon AY, Siroy AE, Karpinets TV, Stingo FC, Baladandayuthapani V, Tetzlaff MT, Wargo JA, Chen K, Forget MA, Haymaker CL, Chen JQ, Meric-Bernstam F, Eterovic AK, Shaw KR, Mills GB, Gershenwald JE, Radvanyi LG, Hwu P, Futreal PA, Gibbons DL, Lazar AJ, Bernatchez C, Davies MA, Woodman SE.

BMC Med. 2016 Oct 25;14(1):168.

4.

Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma.

Siroy AE, Aung PP, Torres-Cabala CA, Tetzlaff MT, Nagarajan P, Milton DR, Curry JL, Ivan D, Prieto VG.

Hum Pathol. 2017 Jan;59:48-54. doi: 10.1016/j.humpath.2016.09.010. Epub 2016 Sep 22.

PMID:
27666765
5.

Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression.

Roszik J, Wu CJ, Siroy AE, Lazar AJ, Davies MA, Woodman SE, Kwong LN.

Sci Rep. 2016 Jan 20;6:19649. doi: 10.1038/srep19649.

6.

Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutations.

Stockman DL, Curry JL, Torres-Cabala CA, Watson IR, Siroy AE, Bassett RL, Zou L, Patel KP, Luthra R, Davies MA, Wargo JA, Routbort MA, Broaddus RR, Prieto VG, Lazar AJ, Tetzlaff MT.

J Cutan Pathol. 2015 May;42(5):308-17. doi: 10.1111/cup.12481. Epub 2015 Mar 24.

PMID:
25754356
7.

Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma.

Siroy AE, Boland GM, Milton DR, Roszik J, Frankian S, Malke J, Haydu L, Prieto VG, Tetzlaff M, Ivan D, Wang WL, Torres-Cabala C, Curry J, Roy-Chowdhuri S, Broaddus R, Rashid A, Stewart J, Gershenwald JE, Amaria RN, Patel SP, Papadopoulos NE, Bedikian A, Hwu WJ, Hwu P, Diab A, Woodman SE, Aldape KD, Luthra R, Patel KP, Shaw KR, Mills GB, Mendelsohn J, Meric-Bernstam F, Kim KB, Routbort MJ, Lazar AJ, Davies MA.

J Invest Dermatol. 2015 Feb;135(2):508-515. doi: 10.1038/jid.2014.366. Epub 2014 Aug 22.

8.

A novel approach: chest wall cyst excised by MIS.

AlJamal YN, Siroy AE, Farley DR.

J Surg Case Rep. 2013 Sep 26;2013(9). pii: rjt085. doi: 10.1093/jscr/rjt085.

9.

Primary melanoma of the bladder.

Siroy AE, MacLennan GT.

J Urol. 2011 Mar;185(3):1096-7. doi: 10.1016/j.juro.2010.12.004. Epub 2011 Jan 21. No abstract available.

PMID:
21256523
10.

Acneiform eruptions associated with epidermal growth factor receptor-targeted chemotherapy.

DeWitt CA, Siroy AE, Stone SP.

J Am Acad Dermatol. 2007 Mar;56(3):500-5. Epub 2006 Dec 12.

PMID:
17166623

Supplemental Content

Loading ...
Support Center